lactic acid has been researched along with Asthma in 46 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Plasma albuterol was significantly correlated with serum lactate concentration after adjusting for asthma severity." | 9.19 | Albuterol administration is commonly associated with increases in serum lactate in patients with asthma treated for acute exacerbation of asthma. ( Aubuchon, K; Ferguson, I; House, SL; Johnson, K; Lewis, LM; Matsuda, K; Schneider, J, 2014) |
| " In this study, we have evaluated anti-asthmatic efficacy of inhalable montelukast-loaded large porous particulate formulations in ovalbumin-induced rat airway inflammation model that mimics asthma." | 7.80 | Aerosolized montelukast polymeric particles-an alternative to oral montelukast-alleviate symptoms of asthma in a rodent model. ( Ahsan, F; Gupta, N; Patel, B, 2014) |
| " Laboratory findings showed hypokalemia, hypophosphatemia, and lactic acidosis." | 7.78 | Lactic acidosis following intentional overdose by inhalation of salmeterol and fluticasone. ( Hantson, P; Manara, A; Thys, F; Vanpee, D, 2012) |
| " His case was reviewed, and the lactic acidosis was thought to be caused by inhaled β2-agonist use." | 7.77 | Take my breath away: a case of lactic acidosis in an asthma exacerbation. ( McGonigle, R; Woods, RA, 2011) |
| "Estimate influences of standard physical exercise on lactic acid concentration and acid-base equilibrium in patients with mild and moderate bronchial asthma compared with healthy trained persons and do not ones." | 7.72 | [Influence of physical effort on concentration of lactic acid and acid-base equilibrium in patients with mild and moderate bronchial asthma]. ( Dziedziczko, A; Kuźmiński, A, 2004) |
| "Plasma albuterol was significantly correlated with serum lactate concentration after adjusting for asthma severity." | 5.19 | Albuterol administration is commonly associated with increases in serum lactate in patients with asthma treated for acute exacerbation of asthma. ( Aubuchon, K; Ferguson, I; House, SL; Johnson, K; Lewis, LM; Matsuda, K; Schneider, J, 2014) |
| "Montelukast, a cysteinyl leukotriene receptor antagonist available as oral tablets, is used as a second-line therapy in asthma." | 3.85 | Aerosolizable modified-release particles of montelukast improve retention and availability of the drug in the lungs. ( Ahsan, F; Patel, B; Rashid, J, 2017) |
| " In this study, we have evaluated anti-asthmatic efficacy of inhalable montelukast-loaded large porous particulate formulations in ovalbumin-induced rat airway inflammation model that mimics asthma." | 3.80 | Aerosolized montelukast polymeric particles-an alternative to oral montelukast-alleviate symptoms of asthma in a rodent model. ( Ahsan, F; Gupta, N; Patel, B, 2014) |
| " Laboratory findings showed hypokalemia, hypophosphatemia, and lactic acidosis." | 3.78 | Lactic acidosis following intentional overdose by inhalation of salmeterol and fluticasone. ( Hantson, P; Manara, A; Thys, F; Vanpee, D, 2012) |
| " His case was reviewed, and the lactic acidosis was thought to be caused by inhaled β2-agonist use." | 3.77 | Take my breath away: a case of lactic acidosis in an asthma exacerbation. ( McGonigle, R; Woods, RA, 2011) |
| "Estimate influences of standard physical exercise on lactic acid concentration and acid-base equilibrium in patients with mild and moderate bronchial asthma compared with healthy trained persons and do not ones." | 3.72 | [Influence of physical effort on concentration of lactic acid and acid-base equilibrium in patients with mild and moderate bronchial asthma]. ( Dziedziczko, A; Kuźmiński, A, 2004) |
| "Terbutaline is a prohibited drug except for athletes with a therapeutic use exemption certificate; terbutaline's effects on endurance performance are relatively unknown." | 2.90 | The Effects of Inhaled Terbutaline on 3-km Running Time-Trial Performance. ( Chester, NJ; Dickinson, JW; Loosemore, M; Molphy, J; Whyte, G, 2019) |
| " QTc, blood pressure and heart rate over 12h, and plasma lactate and glucose over 3h following dosing were assessed." | 2.73 | Tolerability of high cumulative doses of the HFA modulite beclomethasone dipropionate/formoterol combination inhaler in asthmatic patients. ( Acerbi, D; Borrill, Z; Meuleners, L; Piccinno, A; Poli, G; Singh, D; Woodcock, A, 2008) |
| "While respiratory alkalosis occurred in patients with better preservation of FEV1, respiratory acidosis was observed with more severe airway obstruction, as was increased lactate in the majority of patients, independent of PaO(2) and PaCO(2) levels." | 1.39 | Acid-base patterns in acute severe asthma. ( Adrogué, HJ; Gonzalez, S; Menga, G; Raimondi, GA; Zaltsman, J, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (15.22) | 18.7374 |
| 1990's | 5 (10.87) | 18.2507 |
| 2000's | 7 (15.22) | 29.6817 |
| 2010's | 24 (52.17) | 24.3611 |
| 2020's | 3 (6.52) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, X | 1 |
| Zuo, X | 1 |
| Zhou, Z | 1 |
| Gu, Y | 1 |
| Zheng, H | 1 |
| Wang, X | 2 |
| Wang, G | 1 |
| Xu, C | 1 |
| Wang, F | 1 |
| Niu, Y | 1 |
| Nie, Q | 1 |
| Dong, L | 1 |
| Zhang, J | 1 |
| Liu, SF | 1 |
| Song, W | 1 |
| Wu, G | 1 |
| Song, D | 1 |
| Guyther, J | 1 |
| Cantwell, L | 1 |
| Morris, AS | 1 |
| Sebag, SC | 1 |
| Paschke, JD | 1 |
| Wongrakpanich, A | 1 |
| Ebeid, K | 1 |
| Anderson, ME | 1 |
| Grumbach, IM | 1 |
| Salem, AK | 1 |
| Daniels, CE | 1 |
| Litin, SC | 1 |
| Bundrick, JB | 1 |
| Qian, X | 1 |
| Aboushousha, R | 1 |
| van de Wetering, C | 1 |
| Chia, SB | 1 |
| Amiel, E | 1 |
| Schneider, RW | 1 |
| van der Velden, JLJ | 1 |
| Lahue, KG | 1 |
| Hoagland, DA | 1 |
| Casey, DT | 1 |
| Daphtary, N | 1 |
| Ather, JL | 1 |
| Randall, MJ | 1 |
| Aliyeva, M | 1 |
| Black, KE | 1 |
| Chapman, DG | 1 |
| Lundblad, LKA | 1 |
| McMillan, DH | 1 |
| Dixon, AE | 1 |
| Anathy, V | 1 |
| Irvin, CG | 1 |
| Poynter, ME | 1 |
| Wouters, EFM | 1 |
| Vacek, PM | 1 |
| Henket, M | 1 |
| Schleich, F | 1 |
| Louis, R | 1 |
| van der Vliet, A | 1 |
| Janssen-Heininger, YMW | 1 |
| Molphy, J | 1 |
| Dickinson, JW | 1 |
| Chester, NJ | 1 |
| Loosemore, M | 1 |
| Whyte, G | 1 |
| Papamichael, MM | 1 |
| Katsardis, C | 1 |
| Erbas, B | 1 |
| Itsiopoulos, C | 1 |
| Tsoukalas, D | 1 |
| Raimondi, GA | 1 |
| Gonzalez, S | 1 |
| Zaltsman, J | 1 |
| Menga, G | 1 |
| Adrogué, HJ | 1 |
| Lewis, LM | 2 |
| Ferguson, I | 2 |
| House, SL | 2 |
| Aubuchon, K | 2 |
| Schneider, J | 2 |
| Johnson, K | 2 |
| Matsuda, K | 2 |
| de Oliveira, JF | 1 |
| Garreto, DV | 1 |
| da Silva, MC | 1 |
| Fortes, TS | 1 |
| de Oliveira, RB | 1 |
| Nascimento, FR | 1 |
| Da Costa, FB | 1 |
| Grisotto, MA | 1 |
| Nicolete, R | 1 |
| Patel, B | 3 |
| Gupta, N | 2 |
| Ahsan, F | 3 |
| Rodrigo, GJ | 1 |
| Senthilkumaran, S | 1 |
| Shah, S | 1 |
| Menezes, RG | 1 |
| Thirumalaikolundusubramanian, P | 1 |
| Claret, PG | 1 |
| Bobbia, X | 1 |
| de La Coussaye, JE | 1 |
| Greguš, M | 1 |
| Foret, F | 1 |
| Kindlová, D | 1 |
| Pokojová, E | 1 |
| Plutinský, M | 1 |
| Doubková, M | 1 |
| Merta, Z | 1 |
| Binková, I | 1 |
| Skřičková, J | 1 |
| Kubáň, P | 1 |
| Tomasiak-Lozowska, MM | 1 |
| Rusak, T | 1 |
| Misztal, T | 1 |
| Bodzenta-Lukaszyk, A | 1 |
| Tomasiak, M | 1 |
| McAvoy, JC | 1 |
| Khurana, A | 1 |
| Rashid, J | 1 |
| Matsuo, Y | 1 |
| Ishihara, T | 1 |
| Ishizaki, J | 1 |
| Miyamoto, K | 1 |
| Higaki, M | 1 |
| Yamashita, N | 1 |
| Kovacevic, A | 1 |
| Schwahn, B | 1 |
| Schuster, A | 1 |
| Oh, YJ | 1 |
| Lee, J | 1 |
| Seo, JY | 1 |
| Rhim, T | 1 |
| Kim, SH | 1 |
| Yoon, HJ | 1 |
| Lee, KY | 1 |
| Matsunaga, Y | 1 |
| Inoue, H | 1 |
| Fukuyama, S | 1 |
| Yoshida, H | 1 |
| Moriwaki, A | 1 |
| Matsumoto, T | 1 |
| Matsumoto, K | 1 |
| Asai, Y | 1 |
| Kubo, M | 1 |
| Yoshimura, A | 1 |
| Nakanishi, Y | 1 |
| McGonigle, R | 1 |
| Woods, RA | 1 |
| Ostroukhova, M | 1 |
| Goplen, N | 1 |
| Karim, MZ | 1 |
| Michalec, L | 1 |
| Guo, L | 1 |
| Liang, Q | 1 |
| Alam, R | 2 |
| Manara, A | 1 |
| Hantson, P | 1 |
| Vanpee, D | 1 |
| Thys, F | 1 |
| Dziedziczko, A | 1 |
| Kuźmiński, A | 1 |
| Pytte, M | 1 |
| Opdahl, H | 1 |
| Skaga, NO | 1 |
| Jee, R | 1 |
| Brownlow, H | 1 |
| Hulme, J | 1 |
| Bohn, D | 1 |
| Singh, D | 1 |
| Piccinno, A | 1 |
| Borrill, Z | 1 |
| Poli, G | 1 |
| Acerbi, D | 1 |
| Meuleners, L | 1 |
| Woodcock, A | 1 |
| Hrabac, B | 1 |
| Shephard, RJ | 1 |
| Inbar, O | 1 |
| Alvarez, DX | 1 |
| Lyons, HA | 1 |
| Henriksen, JM | 1 |
| Nielsen, TT | 1 |
| Dahl, R | 1 |
| Robertson, W | 1 |
| Simkins, J | 1 |
| O'Hickey, SP | 1 |
| Freeman, S | 1 |
| Cayton, RM | 1 |
| Counil, FP | 1 |
| Varray, A | 1 |
| Karila, C | 1 |
| Hayot, M | 1 |
| Voisin, M | 1 |
| Préfaut, C | 1 |
| Rabbat, A | 1 |
| Laaban, JP | 1 |
| Boussairi, A | 1 |
| Rochemaure, J | 1 |
| Forsythe, PA | 1 |
| Rankin, JA | 1 |
| Boyars, MC | 1 |
| Lett-Brown, MA | 1 |
| Grant, JA | 1 |
| Cochrane, LM | 1 |
| Clark, CJ | 1 |
| Freeman, W | 1 |
| Nute, MG | 1 |
| Williams, C | 1 |
| Okrent, DG | 1 |
| Tessler, S | 1 |
| Twersky, RA | 1 |
| Tashkin, DP | 1 |
| Hollmann, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase II, Randomized, Modified Single-Blind, Placebo-Controlled Dose Escalation Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma[NCT00683449] | Phase 2 | 29 participants (Actual) | Interventional | 2008-06-30 | Terminated (stopped due to Data from Dose Groups 1,2 and other MN-221 studies resulted in the determination of a more appropriate dosing scheme for MN-221 in subjects with asthma.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The primary efficacy summary was change from Baseline in FEV1 (percent predicted), at Hour 2. Baseline was defined as FEV1 (percent predicted) after two doses of albuterol (5 mg each) and ipratropium (0.5 mg each) and FEV1 (percent predicted) FEV1 at Hour 2 was defined as the FEV1 (percent predicted) at 2 hours after the start of the infusion of MN-221 or placebo. Change from Baseline in FEV1 (percent predicted), was summarized by treatment group at Hour 2. (NCT00683449)
Timeframe: Baseline and Hour 2
| Intervention | FEV1 (percent of predicted) (Mean) |
|---|---|
| 240 μg MN-221 i.v. (Intravenous) Infusion for 15 Minutes | 16.57 |
| MN-221 Placebo i.v. Infusion | 3.88 |
| 1,000-1,080 μg MN-221 i.v. | 3.03 |
| 450 μg MN-221 i.v. for 15 Minutes | 4.27 |
| 1,995 μg MN-221 i.v. Over 15 Minutes and 25 Minutes | -0.82 |
FEV1 (L) was determined over time using a spirometer. Measure the mean change in FEV1 (L) from Baseline. (NCT00683449)
Timeframe: Baseline to Hour 2
| Intervention | liters per second (Mean) |
|---|---|
| MN-221 at 16.0 μg/Min for 15 Min (Total 240 μg) | 0.60 |
| Placebo Administered Intravenously | 0.10 |
| 450 μg MN-221 Given i.v. | 0.12 |
| 1,000-1,080 μg MN-221 Given i.v. for 15 Minutes | 0.10 |
| 1,995 MN-221 Administered i.v. for 15 Minutes and 25 Minutes | -0.02 |
After a patient in the emergency department (ED) presents with an acute exacerbation of asthma, the hospital proceeds with SOC procedures for this condition. Despite treatment in the ED, it is sometimes necessary to admit the patient into the hospital. In the study described here, the rate of hospital admissions was recorded. (NCT00683449)
Timeframe: Hour -1.5 through Hour 5
| Intervention | participants (Number) |
|---|---|
| 240 μg MN-221 i.v. (Intravenous) Infusion for 15 Minutes | 0 |
| MN-221 Placebo i.v. Infusion | 7 |
| 1,000-1,080 μg MN-221 i.v. | 0 |
| 450 μg MN-221 i.v. for 15 Minutes | 3 |
| 1,995 μg MN-221 i.v. Over 15 Minutes and 25 Minutes | 1 |
3 reviews available for lactic acid and Asthma
| Article | Year |
|---|---|
PLGA-Based Micro/Nanoparticles: An Overview of Their Applications in Respiratory Diseases.
Topics: Asthma; Drug Carriers; Humans; Lactic Acid; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polygl | 2023 |
Big Tests in Little People.
Topics: Asthma; Biomarkers; Child; Fibrin Fibrinogen Degradation Products; Heart Diseases; Humans; Infection | 2021 |
Exercise-induced bronchospasm - pathophysiology and treatment.
Topics: Adult; Age Factors; Asthma; Asthma, Exercise-Induced; Bronchodilator Agents; Carbon Dioxide; Child; | 1981 |
6 trials available for lactic acid and Asthma
| Article | Year |
|---|---|
The Effects of Inhaled Terbutaline on 3-km Running Time-Trial Performance.
Topics: Administration, Inhalation; Adult; Asthma; Athletic Performance; Female; Forced Expiratory Volume; H | 2019 |
Albuterol administration is commonly associated with increases in serum lactate in patients with asthma treated for acute exacerbation of asthma.
Topics: Adult; Albuterol; Asthma; Bronchodilator Agents; Disease Progression; Double-Blind Method; Drug Ther | 2014 |
Tolerability of high cumulative doses of the HFA modulite beclomethasone dipropionate/formoterol combination inhaler in asthmatic patients.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Anti-Asthmatic Agents; Anti-Inflammator | 2008 |
Does single dose salmeterol affect exercise capacity in asthmatic men?
Topics: Adult; Albuterol; Asthma; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Exercise T | 1994 |
Wingate test performance in children with asthma: aerobic or anaerobic limitation?
Topics: Adolescent; Anaerobic Threshold; Asthma; Child; Epinephrine; Exercise Test; Humans; Lactic Acid; Mal | 1997 |
Benefits and problems of a physical training programme for asthmatic patients.
Topics: Adolescent; Adult; Asthma; Carbon Dioxide; Exercise Therapy; Female; Forced Expiratory Volume; Heart | 1990 |
37 other studies available for lactic acid and Asthma
| Article | Year |
|---|---|
Hydrogen Attenuates Allergic Inflammation by Reversing Energy Metabolic Pathway Switch.
Topics: Animals; Asthma; Bronchoconstrictor Agents; Cells, Cultured; Disease Models, Animal; Female; Glycoly | 2020 |
Cationic CaMKII Inhibiting Nanoparticles Prevent Allergic Asthma.
Topics: Animals; Asthma; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Drug Delivery Systems; Lactic A | 2017 |
Clinical pearls in pulmonary diseases.
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Asthmatic Agents; Asthma; Confusion; Cough; Female; Heart | 2017 |
IL-1/inhibitory κB kinase ε-induced glycolysis augment epithelial effector function and promote allergic airways disease.
Topics: Animals; Antigens, Dermatophagoides; Asthma; Cells, Cultured; Cohort Studies; Disease Models, Animal | 2018 |
Urinary organic acids as biomarkers in the assessment of pulmonary function in children with asthma.
Topics: Acids; Asthma; Biomarkers; Breath Tests; Child; Child, Preschool; Female; Forced Expiratory Volume; | 2019 |
Acid-base patterns in acute severe asthma.
Topics: Acidosis, Respiratory; Acute Disease; Adult; Aged; Aged, 80 and over; Alkalosis, Respiratory; Asthma | 2013 |
Therapeutic potential of biodegradable microparticles containing Punica granatum L. (pomegranate) in murine model of asthma.
Topics: Animals; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, | 2013 |
Low-molecular-weight heparin (LMWH)-loaded large porous PEG-PLGA particles for the treatment of asthma.
Topics: Administration, Inhalation; Airway Remodeling; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Age | 2014 |
Serum lactate increase during acute asthma treatment: a new piece of the puzzle.
Topics: Albuterol; Asthma; Bronchodilator Agents; Female; Humans; Lactic Acid; Male | 2014 |
Salmeterol and lactic acidosis: clinical and educational aspects.
Topics: Acidosis, Lactic; Albuterol; Androstadienes; Asthma; Drug Overdose; Female; Humans; Intention; Lacti | 2014 |
Too much testing?
Topics: Albuterol; Asthma; Bronchodilator Agents; Female; Humans; Lactic Acid; Male | 2014 |
Response.
Topics: Albuterol; Asthma; Bronchodilator Agents; Female; Humans; Lactic Acid; Male | 2014 |
Aerosolized montelukast polymeric particles-an alternative to oral montelukast-alleviate symptoms of asthma in a rodent model.
Topics: Acetates; Aerosols; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bronchoalveola | 2014 |
Monitoring the ionic content of exhaled breath condensate in various respiratory diseases by capillary electrophoresis with contactless conductivity detection.
Topics: Acetates; Adult; Aged; Ammonium Compounds; Asthma; Breath Tests; Butyrates; Calcium; Chlorides; Crow | 2015 |
Reduced clot retraction rate and altered platelet energy production in patients with asthma.
Topics: Adrenal Cortex Hormones; Adult; Aged; Asthma; Blood Platelets; Case-Control Studies; Clot Retraction | 2016 |
Getting Burned by Lactic Acid.
Topics: Adolescent; Adrenergic beta-Agonists; Asthma; Humans; Hyperlactatemia; Lactic Acid; Male; Unnecessar | 2016 |
Aerosolizable modified-release particles of montelukast improve retention and availability of the drug in the lungs.
Topics: Acetates; Administration, Inhalation; Animals; Anti-Asthmatic Agents; Asthma; Biological Availabilit | 2017 |
Effect of betamethasone phosphate loaded polymeric nanoparticles on a murine asthma model.
Topics: Animals; Asthma; Betamethasone; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Drug Delivery | 2009 |
Hyperlactic acidosis as metabolic side-effect of albuterol and theophylline in acute severe asthma.
Topics: Acidosis, Lactic; Administration, Inhalation; Adolescent; Albuterol; Anti-Asthmatic Agents; Anti-Inf | 2010 |
Preparation of budesonide-loaded porous PLGA microparticles and their therapeutic efficacy in a murine asthma model.
Topics: Animals; Asthma; Bicarbonates; Bronchodilator Agents; Budesonide; Drug Carriers; Female; Lactic Acid | 2011 |
Effects of a Janus kinase inhibitor, pyridone 6, on airway responses in a murine model of asthma.
Topics: Animals; Asthma; Benzimidazoles; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Capsules; | 2011 |
Take my breath away: a case of lactic acidosis in an asthma exacerbation.
Topics: Acidosis, Lactic; Adult; Asthma; Diagnosis, Differential; Electrocardiography; Humans; Lactic Acid; | 2011 |
The role of low-level lactate production in airway inflammation in asthma.
Topics: Adult; Aged; Animals; Asthma; Case-Control Studies; Cell Proliferation; Cells, Cultured; Cytokines; | 2012 |
Lactic acidosis following intentional overdose by inhalation of salmeterol and fluticasone.
Topics: Acidosis, Lactic; Administration, Inhalation; Adolescent; Adrenergic beta-2 Receptor Agonists; Albut | 2012 |
[Influence of physical effort on concentration of lactic acid and acid-base equilibrium in patients with mild and moderate bronchial asthma].
Topics: Acid-Base Equilibrium; Adolescent; Adult; Asthma; Asthma, Exercise-Induced; Blood Gas Analysis; Carb | 2004 |
Grave acidosis after severe anaphylactic bronchospasm: friend or foe?
Topics: Acidosis; Adult; Anaphylaxis; Anti-Inflammatory Agents; Asthma; Blood Gas Analysis; Blood Glucose; B | 2007 |
Hyperlactaemia due to nebulised salbutamol.
Topics: Adult; Albuterol; Asthma; Bronchodilator Agents; Female; Humans; Lactic Acid; Nebulizers and Vaporiz | 2007 |
Hyperlactaemia in asthmatics.
Topics: Albuterol; Asthma; Bronchodilator Agents; Humans; Lactic Acid | 2007 |
Metabolic acidosis in severe asthma: Is it the disease or is it the doctor?
Topics: Acidosis; Acute Disease; Albuterol; Asthma; Blood Gas Analysis; Bronchodilator Agents; Child, Presch | 2007 |
[The effect of corticosteroid therapy and global respiratory insufficiency on lactate and amino acid levels in the blood].
Topics: Amino Acids; Asthma; Humans; Lactates; Lactic Acid; Methylprednisolone; Respiratory Insufficiency | 1984 |
Exercise-induced asthma - a comparison between two modes of exercise stress.
Topics: Adult; Asthma; Asthma, Exercise-Induced; Blood Gas Analysis; Female; Humans; Hydrogen-Ion Concentrat | 1981 |
Effects of physical training on plasma citrate and exercise-induced asthma.
Topics: Adolescent; Asthma; Asthma, Exercise-Induced; Blood Glucose; Child; Citrates; Citric Acid; Female; H | 1981 |
Hyperlactatemia during acute severe asthma.
Topics: Acidosis, Lactic; Acute Disease; Adult; Arteries; Asthma; Blood Gas Analysis; Disease Progression; F | 1998 |
Sensitivity of basophils to histamine releasing factor(s) of various origin: dependency on allergic phenotype of the donor and surface-bound IgE.
Topics: Asthma; Basophils; Biomarkers, Tumor; Bronchoalveolar Lavage Fluid; Histamine Release; Humans; Hyper | 1990 |
The effect of endurance running training on asthmatic adults.
Topics: Adolescent; Adult; Asthma; Asthma, Exercise-Induced; Cardiovascular System; Female; Forced Expirator | 1989 |
Metabolic acidosis not due to lactic acidosis in patients with severe acute asthma.
Topics: Acid-Base Equilibrium; Acidosis; Acidosis, Lactic; Adolescent; Adult; Aged; Asthma; Bicarbonates; Bl | 1987 |
[Exercise, training and sports in children with asthma from the sports medicine viewpoint].
Topics: Adolescent; Asthma; Asthma, Exercise-Induced; Child; Child Development; Heart Rate; Humans; Lactates | 1985 |